Amneal Pharmaceuticals, Inc. AMRX Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s gross margin?
- Amneal Pharmaceuticals, Inc. (AMRX) reported gross margin of 38.7% in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s gross margin changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s gross margin increased by 5.4% year-over-year, from 36.7% to 38.7%.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s gross margin?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s gross margin has grown at a 2.1% compound annual growth rate (CAGR), from 33.3% to 36.9%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.